Although tumor vasculature proteins such as vascular endothelial growth factor, αvβ3 integrin, and platelet derived growth factor are well known, resistance to therapies targeting these proteins reveals that tumor vasculature is a complex system that remains incompletely characterized [5]. This evidence concerns the gene VEGFA and neoplasm.